Collegium Pharmaceutical (COLL) Restructuring Costs (2021 - 2025)

Collegium Pharmaceutical's Restructuring Costs history runs 3 years deep, the most recent figure standing at $10.9 million for Q3 2025.

• In Q3 2025, Restructuring Costs rose 39.88% year-over-year to $10.9 million; the TTM figure through Sep 2025 stood at $43.5 million (up 50.89% YoY), while the FY2024 annual figure was $33.7 million, up 4.27% from the prior year.
• Restructuring Costs was $10.9 million for Q3 2025 at Collegium Pharmaceutical, up from $9.8 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $13.3 million in Q1 2025 to a low of $4.6 million in Q4 2021.
• Historically, Restructuring Costs has averaged $9.0 million across 3 years, with a median of $9.0 million in 2024.
• Biggest YoY gain for Restructuring Costs was 54.11% in 2025; the steepest drop was 25.49% in 2025.
• A 3-year view of Restructuring Costs shows it stood at $4.6 million in 2021, then surged by 106.92% to $9.5 million in 2024, then climbed by 15.12% to $10.9 million in 2025.
• The last three Restructuring Costs figures came in at $10.9 million (Q3 2025), $9.8 million (Q2 2025), and $13.3 million (Q1 2025), per Business Quant data.